Novo Nordisk's Once-Weekly Insulin Awiqli Targets India's 100M+ Diabetes Market

Insulin icodec cuts injection burden 86% vs daily basal insulins, but pricing remains undisclosed as Novo Nordisk eyes scale in a price-sensitive, generics-heavy Indian market.

ndtv-profit-business · 7/9/2026, 7:03:36 AM · Ask about this →